| Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics A Menter, A Gottlieb, SR Feldman, AS Van Voorhees, CL Leonardi, ... Journal of the American Academy of Dermatology 58 (5), 826-850, 2008 | 1940 | 2008 |
| Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional … A Menter, NJ Korman, CA Elmets, SR Feldman, JM Gelfand, KB Gordon, ... Journal of the American Academy of Dermatology 61 (3), 451-485, 2009 | 1665 | 2009 |
| Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia GJ Anhalt, SC Kim, JR Stanley, NJ Korman, DA Jabs, M Kory, H Izumi, ... New England Journal of Medicine 323 (25), 1729-1735, 1990 | 1390 | 1990 |
| The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators LS Chan, AR Ahmed, GJ Anhalt, W Bernauer, KD Cooper, MJ Elder, ... Archives of dermatology 138 (3), 370-379, 2002 | 1005 | 2002 |
| Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics A Menter, BE Strober, DH Kaplan, D Kivelevitch, EF Prater, B Stoff, ... Journal of the American Academy of Dermatology 80 (4), 1029-1072, 2019 | 919 | 2019 |
| Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological … C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ... Annals of the rheumatic diseases 73 (6), 990-999, 2014 | 765 | 2014 |
| Two phase 3 trials of adalimumab for hidradenitis suppurativa AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ... New England Journal of Medicine 375 (5), 422-434, 2016 | 763 | 2016 |
| Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy … K Papp, K Reich, CL Leonardi, L Kircik, S Chimenti, RGB Langley, CC Hu, ... Journal of the American Academy of Dermatology 73 (1), 37-49, 2015 | 715 | 2015 |
| Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on … A Gottlieb, NJ Korman, KB Gordon, SR Feldman, M Lebwohl, JYM Koo, ... Journal of the American Academy of Dermatology 58 (5), 851-864, 2008 | 679 | 2008 |
| Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus DF Murrell, S Dick, AR Ahmed, M Amagai, MA Barnadas, L Borradori, ... Journal of the American Academy of Dermatology 58 (6), 1043-1046, 2008 | 643 | 2008 |
| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 616 | 2018 |
| National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening AB Kimball, D Gladman, JM Gelfand, K Gordon, EJ Horn, NJ Korman, ... Journal of the American Academy of Dermatology 58 (6), 1031-1042, 2008 | 605 | 2008 |
| Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based … A Menter, NJ Korman, CA Elmets, SR Feldman, JM Gelfand, KB Gordon, ... Journal of the American Academy of Dermatology 65 (1), 137-174, 2011 | 591 | 2011 |
| Protective effects of silymarin against photocarcinogenesis in a mouse skin model SK Katiyar, NJ Korman, H Mukhtar, R Agarwal Journal of the National Cancer Institute 89 (8), 556-565, 1997 | 501 | 1997 |
| Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities CA Elmets, CL Leonardi, DMR Davis, JM Gelfand, J Lichten, NN Mehta, ... Journal of the American Academy of Dermatology 80 (4), 1073-1113, 2019 | 472 | 2019 |
| Management of psoriasis as a systemic disease: what is the evidence? NJ Korman British Journal of Dermatology 182 (4), 840-848, 2020 | 444 | 2020 |
| Topical capsaicin treatment of chronic postherpetic neuralgia JE Bernstein, NJ Korman, DR Bickers, MV Dahl, LE Millikan Journal of the American Academy of Dermatology 21 (2), 265-270, 1989 | 398 | 1989 |
| Diagnosis and management of pemphigus: Recommendations of an international panel of experts DF Murrell, S Peña, P Joly, B Marinovic, T Hashimoto, LA Diaz, AA Sinha, ... Journal of the American Academy of Dermatology 82 (3), 575-585. e1, 2020 | 367 | 2020 |
| Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris NJ Korman, RW Eyre, V Klaus-Kovtun, JR Stanley New England Journal of Medicine 321 (10), 631-635, 1989 | 330 | 1989 |
| Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation A Robinson, AS Van Voorhees, S Hsu, NJ Korman, MG Lebwohl, ... Journal of the American Academy of Dermatology 67 (2), 279-288, 2012 | 327 | 2012 |
